March 29, 2022
Japan’s health ministry approved a batch of new medicines on March 28 including Bayer Yakuhin’s chronic kidney disease (CDK) treatment Kerendia (finerenone) and Chugai Pharmaceutical’s Vabysmo (faricimab), the first bispecific antibody for eyes. Kerendia won the green light for the...read more